Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Lamagni
T L
TL
Health Protection Agency Centre for Infections, London, United Kingdom. Theresa.lamagni@hpa.org.uk
Campbell
C
C
Pezzoli
L
L
Johnson
E
E
D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D001769:Blood / Q000382:microbiology*; D000077336:Caspofungin; D003937:Diagnosis, Differential; D054714:Echinocandins; D004866:Equipment Contamination; D005189:False Positive Reactions; D016469:Fungemia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D009181:Mycoses / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D010143:Paecilomyces / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification* / Q000648:ultrastructure; D010456:Peptides, Cyclic / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013045:Species Specificity; D014230:Triazoles / Q000494:pharmacology; D006113:United Kingdom / Q000453:epidemiology; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole